Giardini, V., Carrer, A., Casati, M., Contro, E., Vergani, P., & Gambacorti Passerini, C. (2020). Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction. AMERICAN JOURNAL OF HEMATOLOGY, 95(8), E188-E191.Dettaglio
Ramazzotti, D., Angaroni, F., Maspero, D., Gambacorti-Passerini, C., Antoniotti, M., Graudenzi, A., et al. (2020). Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations [Rapporto tecnico].Dettaglio
Brummendorf, T., Gambacorti Passerini, C., Bushmakin, A., Cappelleri, J., Viqueira, A., Reisman, A., et al. (2020). Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia. ANNALS OF HEMATOLOGY, 99(6), 1241-1249.Dettaglio
Colombo, F., Pintarelli, G., Galvan, A., Noci, S., Corli, O., Skorpen, F., et al. (2020). Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients. SCIENTIFIC REPORTS, 10(1).Dettaglio
Hochhaus, A., Gambacorti Passerini, C., Abboud, C., Gjertsen, B., Brummendorf, T., Smith, B., et al. (2020). Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study. LEUKEMIA, 34(8), 2125-2137.Dettaglio